injectable protein based HCV infection therapies (Apollo Life Sciences)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinjectable protein based HCV infection therapies (Apollo Life Sciences)
Drug Alias Nameinjectable protein based hepatitis C virus infection therapies (Apollo Life Sciences)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesApollo Life Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApollo Life Sciences
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A